Current status of hypertension in both China and the globe
In China, there are hundreds of millions of hypertensive cases [1], which is a huge public health burden and challenge, and cost every year a large amount of public health and medical resources. At present, the “three rates” (awareness, treatment, and control rates) of hypertension in China are not high enough [2], and hypertension is still the leading cause of mortality and disability among Chinese residents. Although there are a large number of medical staffs, experts, scholars and researchers working tirelessly on the front line, there is still a long way to go for prevention and control of hypertension in China and the globe (Table 1).
Table 1 Key data of hypertension in adults in both China (aged ≥18 years) and the globe (aged 30–79 years)
Total Cases Aware Diagnosed & Treated Under Control
(or prevalence)